Qlife updates on process for COVID-19 test
Due to increased requests for information on route to market for Qlife’s COVID-19 test the company is updating the following: After having finalized the licensing agreement to COVID-19 chemistries and reagents and having conducted technology integration to the Egoo platform, Qlife plans over the next few weeks to perform in-house verification studies in order to verify test performance. Following positive outcome of in-house verification studies, the expectation is to transfer the test into real life settings at a hospital where the test can be further validated on patient samples.